Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I S Pateras

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Molecular Medicine|February 2, 2012
The tumor suppressor gene ARF as a sensor of oxidative stressM Liontos, I S Pateras, K Evangelou, et al.
Oncogene|July 7, 2010
Why is p53-inducible gene 3 rarely affected in cancer?A Kotsinas, I S Pateras, P S Galanos, et al.
Cell Death and Differentiation|October 6, 2015
Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancyL Golomb, A Sagiv, I S Pateras, et al.
Cancers|March 29, 2023
Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung CancerA N Markou, D Londra, D Stergiopoulou, et al.
The Journal of Pathology|October 2, 2007
Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancerK Apostolopoulou, I S Pateras, K Evangelou, et al.
The Journal of Pathology|June 2, 2006
Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpressionM K Koutsami, P K Tsantoulis, M Kouloukoussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 studyA Psyrri, C Fortpied, G Koutsodontis, et al.
Cell Death and Differentiation|July 16, 2013
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesisK Evangelou, J Bartkova, A Kotsinas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2016
Validation and development of MTH1 inhibitors for treatment of cancerU Warpman Berglund, K Sanjiv, H Gad, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Molecular Medicine|February 2, 2012
The tumor suppressor gene ARF as a sensor of oxidative stressM Liontos, I S Pateras, K Evangelou, et al.
Oncogene|July 7, 2010
Why is p53-inducible gene 3 rarely affected in cancer?A Kotsinas, I S Pateras, P S Galanos, et al.
Cell Death and Differentiation|October 6, 2015
Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancyL Golomb, A Sagiv, I S Pateras, et al.
Cancers|March 29, 2023
Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung CancerA N Markou, D Londra, D Stergiopoulou, et al.
The Journal of Pathology|October 2, 2007
Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancerK Apostolopoulou, I S Pateras, K Evangelou, et al.
The Journal of Pathology|June 2, 2006
Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpressionM K Koutsami, P K Tsantoulis, M Kouloukoussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 studyA Psyrri, C Fortpied, G Koutsodontis, et al.
Cell Death and Differentiation|July 16, 2013
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesisK Evangelou, J Bartkova, A Kotsinas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2016
Validation and development of MTH1 inhibitors for treatment of cancerU Warpman Berglund, K Sanjiv, H Gad, et al.
Pageof 1